Charles River Completes Acquisition of HemaCare
Acquisition establishes a comprehensive cell therapy solution from discovery through commercialization.
Learn more about HemaCare’s role in commercializing patient cell therapies in our new Cell Therapy Solutions video.
HemaCare Solutions
At HemaCare, Quality Comes First
HemaCare maintains the highest regulatory compliance in the industry. Setting the Standard
News and Events
-
Charles River Laboratories Completes the Acquisition of HemaCare CorporationThis acquisition expands Charles River’s scientific capabilities in the emerging, high-growth cell therapy sector, creating a comprehensive portfolio of early-stage research and manufacturing support solutions.READ MORE
-
Charles River Laboratories to Acquire HemaCare CorporationAcquisition expands CRL's scientific capabilities in the high-growth cell therapy market and establishes a comprehensive cell therapy solution from discovery through commercialization.READ MORE
-
HemaCare Expands Its Product Portfolio with GMPrimeTM Bone Marrow AspirateAdvancing cell and gene therapies with the highest quality GMP-compliant bone marrow starting materialREAD MORE
-
HemaCare and Charles River Laboratories Partner to Provide Human-Derived Biological Material to ChinaHemaCare and Charles River Laboratories partner to provide human-derived biological material to ChinaREAD MORE
Interested
Sign up for our newsletter for updates on events, news, and blog posts